- Heterodimerization of Insulin-like Growth Factor Receptor/Epidermal Growth Factor Receptor and Induction of Survivin Expression Counteract the Antitumor Action of Erlotinib. Morgillo, F., Woo, J.K., Kim, E.S., Hong, W.K., Lee, H.Y. Cancer Res. (2006)